×
About 44,815 results

ALLMedicine™ Psoriasis Center

Research & Reviews  12,131 results

Paradoxical reactions and biologic agents: a French cohort study of 9,303 patients.
https://doi.org/10.1111/bjd.21716
The British Journal of Dermatology; Bataille P, Layese R et. al.

Jul 1st, 2022 - Paradoxical reactions (PRs) are defined as the occurrence during biologic therapy of a pathological condition that usually responds to these drugs. To estimate the incidence of PRs and identify risk factors. Multicenter study of the database for t...

Absolute and Relative Risk of New-Onset Psoriasis Associated With Tumor Necrosis Factor...
https://doi.org/10.1001/jamadermatol.2022.2360
JAMA Dermatology; Thein D, Egeberg A et. al.

Jun 30th, 2022 - Tumor necrosis factor-α inhibitor (TNFi)-associated psoriasis is a rare adverse event following TNFi treatment. Data on the risk of developing TNFi-associated psoriasis when treated with TNFi are sparse. To investigate the associated risk between ...

Normal mesenchymal stem cells can improve the abnormal function of T cells in psoriasis...
https://doi.org/10.1111/1346-8138.16490
The Journal of Dermatology; Jiao J, Zhao X et. al.

Jun 30th, 2022 - Psoriasis, a chronic inflammatory skin disease, is a refractory disorder. Previous studies have shown that the imbalance of the T-helper (Th)17/regulatory T cells (Treg) results in the immune imbalance of T cells in psoriatic patients, and that me...

Comparative Effectiveness of Biologics in Clinical Practice: Week 12 Primary Outcomes f...
https://doi.org/10.1111/jdv.18376
Journal of the European Academy of Dermatology and Venere... Pinter A, Puig L et. al.

Jun 30th, 2022 - Clinical trials study treatment outcomes under stringent conditions, capturing incompletely the heterogeneity of patient populations and treatment complexities encountered in real-world practice. To compare the effectiveness of anti-interleukin (I...

Leukocyte mitochondrial DNA copy number is a potential non-invasive biomarker for psori...
https://doi.org/10.1371/journal.pone.0270714
PloS One; Alwehaidah MS, AlFadhli S et. al.

Jun 30th, 2022 - Abnormalities in the mitochondria have been linked to psoriasis, a chronic immune-mediated inflammatory skin disease. The mitochondrial DNA (mtDNA) is present in thousands of copies per cell and altered mtDNA copy number (mtDNA-CN), a common indic...

see more →

Guidelines  22 results

EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 2: specifi...
https://doi.org/10.1111/jdv.16926
Journal of the European Academy of Dermatology and Venere... Nast A, Smith C et. al.

Feb 7th, 2021 - This evidence- and consensus-based guideline on the treatment of psoriasis vulgaris was developed following the EuroGuiDerm Guideline and Consensus Statement Development Manual. The second part of the guideline provides guidance for specific clini...

Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment Pathway.
https://doi.org/10.1159/000512930
Dermatology (Basel, Switzerland); Maul JT, Anzengruber F et. al.

Jan 7th, 2021 - Topical treatment is crucial for the successful management of plaque psoriasis. Topicals are used either as a stand-alone therapy for mild psoriasis or else in combination with UV or systemic treatment for moderate-to-severe disease. For the choic...

Portuguese recommendations for the treatment of psoriasis with biologic therapy.
https://doi.org/10.1684/ejd.2020.3945
European Journal of Dermatology : EJD; Torres T, Tavares Bello R et. al.

Dec 11th, 2020 - Psoriasis is a highly prevalent chronic, inflammatory multisystem disease with a considerable impact on patients' quality of life and the healthcare system. This report presents the recommendations developed by the Portuguese Psoriasis Group of th...

Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis...
https://www.ncbi.nlm.nih.gov/pubmed/33147660
Dermatology Online Journal; Yim RM, Singh I et. al.

Nov 5th, 2020 - Owing to the evolving COVID-19 pandemic and emerging data regarding immunosuppressant therapies for inflammatory cutaneous diseases, dermatologists are being encouraged to reevaluate their patients' treatment regimens to minimize any potential ris...

National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471802
Journal of the American Academy of Dermatology; Gelfand JM, Armstrong AW et. al.

Sep 7th, 2020 - To provide guidance about management of psoriatic disease during the coronavirus disease 2019 (COVID-19) pandemic. A task force (TF) of 18 physician voting members with expertise in dermatology, rheumatology, epidemiology, infectious diseases, and...

see more →

Drugs  910 results see all →

Clinicaltrials.gov  1,705 results

A Study to Assess How Well Certolizumab Pegol Works in Patients With Moderate to Severe Plaque Psoriasis as Part of Routine Clinical Practice
https://clinicaltrials.gov/ct2/show/NCT04053881

Jun 24th, 2022 - The purpose of the study is to assess the effectiveness of certolizumab pegol in patients with moderate to severe plaque psoriasis as part of routine clinical practice.

Metabolic Profiling of Immune Responses in Immune-mediated Diseases
https://clinicaltrials.gov/ct2/show/NCT04864886

Jun 24th, 2022 - The primary objective of this research is to perform in vivo assessment of the metabolic signatures associated with immunity, with particular focus on the immune modulators of wound healing and tissue repair. Perhaps the most demonstrative example...

Effect of Chronic Inflammation on Myocardial Perfusion and Function
https://clinicaltrials.gov/ct2/show/NCT04870827

Jun 24th, 2022 - Study Description: Heart failure (HF) remains a significant public health burden despite expanding and improving treatment options. Clinical and pre-clinical studies have demonstrated compelling relationships between inflammation, myocardial dysfu...

Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in Psoriasis
https://clinicaltrials.gov/ct2/show/NCT04271735

Jun 24th, 2022 - Study Description: Psoriasis is a Th17 linked inflammatory disease and we find that the vitamin B3 analogue nicotinamide riboside (NR) blunts Th1 and Th17 activation in ex-vivo na(SqrRoot) ve and differentiated T cells from control and psoriasis s...

Ustekinumab (Anti-IL-12/23p40 Monoclonal Antibody) in Patients With Leukocyte Adhesion Deficiency Type 1 (LAD1) Who Have Inflammatory Pathology
https://clinicaltrials.gov/ct2/show/NCT03366142

Jun 24th, 2022 - Lymphocyte adhesion deficiency type 1 (LAD1) is an autosomal recessive disorder of leukocyte function. Decreased expression of the <=2 subunit of leukocyte integrins results in abnormal cell-cell and cell extracellular matrix adhesion. This diseas...

see more →

News  3,115 results

Autoimmune disorder drugs top list of meds linked to headache
https://www.mdedge.com/neurology/article/255727/headache-migraine/autoimmune-disorder-drugs-top-list-meds-linked-headache
Randy Dotinga

Jun 23rd, 2022 - DENVER – Monoclonal antibodies, antivirals, immunomodulators, and pulmonary arterial vasodilators top the list of drugs that were most frequently implicated as causes of headaches in a federal side effect database that anyone can contribute to, ac.

Top Medications Most Often Linked to Headache
https://www.medscape.com/viewarticle/976124

Jun 23rd, 2022 - DENVER, Colorado — Monoclonal antibodies, antivirals, immunomodulators, and pulmonary arterial vasodilators top the list of drugs that were most frequently implicated as causes of headaches in a federal side effect database that anyone can contrib...

Postherpetic Pink, Smooth, Annular Convalescing Plaques
https://www.mdedge.com/dermatology/article/255657/dermatopathology/postherpetic-pink-smooth-annular-convalescing-plaques
Caroline A. Gerhardt, MD, Sarah Moore, MD et. al.

Jun 22nd, 2022 - The Diagnosis: Granuloma Annulare A biopsy of a lesion on the right flank demonstrated granulomatous inflammation and interstitial mucin (Figure), characteristic of granuloma annulare (GA). 1,2 Granuloma annulare is a relatively common skin disord.

Identifying contributors to CAD in patients with PsA
https://www.mdedge.com/dermatology/article/255604/psoriatic-arthritis/identifying-contributors-cad-patients-psa

Jun 22nd, 2022 - Key clinical point: Inflammatory and metabolic parameters, including visceral adiposity, potentially contribute to subclinical coronary artery disease (CAD) in patients with psoriatic arthritis (PsA). Major finding: CAD was significantly associate.

Current psoriatic lesions or a personal history of psoriasis correlates with PsA disease activity
https://www.mdedge.com/dermatology/article/255601/psoriatic-arthritis/current-psoriatic-lesions-or-personal-history

Jun 22nd, 2022 - Key clinical point: Patients with psoriatic arthritis (PsA) who had a personal history of psoriasis (pPsA) or a family history of psoriasis and current psoriatic lesions (fPsA/PSO) showed a higher disease activity (DA) and more severe axial joint.

see more →

Patient Education  43 results see all →